Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide +/- Cyclophosphamide in Relapsed/Refractory Multiple Myeloma
NCT02406222Phase 2Active, not recruiting
- Sponsor
- University of Leeds
- Start
- Mar 2016
- Primary completion
- Dec 2022
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM), sponsored by University of Leeds. Started Mar 2016; status: active, not recruiting.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02406222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02406222.